These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 215530

  • 21. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 22. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G, Purtilo D.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract] [Full Text] [Related]

  • 23. Complexity of antigen-antibody systems associated with Epstein-Barr virus.
    Svedmyr A, Demissie A, Klein G, Gergely L, Clifford P.
    Ann N Y Acad Sci; 1971 Jun 21; 177():241-9. PubMed ID: 4333750
    [No Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Niedobitek G.
    Mol Pathol; 2000 Oct 21; 53(5):248-54. PubMed ID: 11091848
    [Abstract] [Full Text] [Related]

  • 25. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.
    Lai PK, Alpers MP.
    Comp Immunol Microbiol Infect Dis; 1979 Oct 21; 2(4):565-85. PubMed ID: 232867
    [No Abstract] [Full Text] [Related]

  • 26. Impaired long-term T cell immunity to Epstein-Barr virus in patients with nasopharyngeal carcinoma.
    Tamura S, Yamazaki A, Kunimoto M, Takemura K, Tabata T, Hinuma Y, Yoshie O.
    Jpn J Cancer Res; 1992 May 21; 83(5):445-9. PubMed ID: 1319984
    [Abstract] [Full Text] [Related]

  • 27. Depression correlated with cellular immunity in systemic immunodeficient Epstein-Barr virus syndrome (SIDES).
    Allen AD, Tilkian SM.
    J Clin Psychiatry; 1986 Mar 21; 47(3):133-5. PubMed ID: 3005245
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM.
    Acta Haematol Pol; 1979 Mar 21; 10(3):183-91. PubMed ID: 228518
    [No Abstract] [Full Text] [Related]

  • 30. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.
    Tanner JE, Wei MX, Alfieri C, Ahmad A, Taylor P, Ooka T, Menezes J.
    J Infect Dis; 1997 Jan 21; 175(1):38-46. PubMed ID: 8985194
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
    Nadala EC, Tan TM, Wong HM, Ting RC.
    J Med Virol; 1996 Sep 21; 50(1):93-6. PubMed ID: 8890046
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Present status of infectious mononucleosis and Epstein Barr virus].
    Ducroix JP, Smail A, Vovan AT, Devauchelle B, Baillet J.
    LARC Med; 1984 Mar 21; 4(3):161-3. PubMed ID: 6325836
    [No Abstract] [Full Text] [Related]

  • 35. Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
    Chan SH, Wallen WC, Levine PH, Periman P, Perlin E.
    Int J Cancer; 1977 Mar 15; 19(3):356-63. PubMed ID: 191408
    [Abstract] [Full Text] [Related]

  • 36. [Immunovirological factors in epitheliomas of the rhinopharynx].
    de-Thé G.
    Bull Cancer; 1975 Mar 15; 62(3):265-76. PubMed ID: 172172
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients.
    Moss DJ, Chan SH, Burrows SR, Chew TS, Kane RG, Staples JA, Kunaratnam N.
    Int J Cancer; 1983 Sep 15; 32(3):301-5. PubMed ID: 6309678
    [Abstract] [Full Text] [Related]

  • 38. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug 15; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 39. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract] [Full Text] [Related]

  • 40. Diagnosis of Epstein-Barr virus-related diseases.
    Linde A.
    Scand J Infect Dis Suppl; 1996 Nov 15; 100():83-8. PubMed ID: 8860358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.